EUVIMEDEUVIMED entdecken
Open Access

CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells

Hye Jeong Yun, Chan Ho Park, Dahye Yun, Hye-Ri Shin, Jeong Dong Lee, Changhee Park, Kiyeon Kim, Heejun Shim, Hyejin Sim, Se Min Kim, Min Jung Kim, Ji Won Park und 8 weitere

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 24.02.2026. Verfasst von Hye Jeong Yun und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, CCAAT-Enhancer-Binding Protein-beta, CTLA-4 Antigen, Tumor Escape. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea, Seoul National University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitors are ineffective in the majority of colorectal cancers (CRCs) that are microsatellite stable. However, the underlying reasons for their unresponsiveness and mechanisms of immune evasion are poorly understood. In the present study, we aimed to elucidate the mechanisms underlying the immune evasion driven by CRC cells.

Methods

We performed single-cell RNA sequencing of tumor tissues from 30 CRC patients and syngeneic mice implanted with transformation-related protein 53 ( Trp53 ) knockout CT26 cells. Gene expression and correlations of individual tumor microenvironment (TME) components were analyzed, and their functional significance was investigated using syngeneic mouse models and cell line co-culture experiments.

Results

CCAAT enhancer-binding protein beta ( CEBPB ) expression was increased in tumor protein 53 ( TP53 )-mutated CRCs. We confirmed that wild-type TP53 negatively regulated CEBPB expression in CRC cell lines. CEBPB expression was associated with decreased intratumoral T cell infiltration and negatively impacted survival in CRC patients. In the intercellular correlation analysis of gene expression, tumor epithelial cell CEBPB expression was significantly correlated with cytotoxic T-lymphocyte associated protein 4 ( CTLA4 ) expression in T cells, especially in regulatory and exhausted T cells. Cebpb overexpression promoted tumor growth in the immunocompetent syngeneic mouse models, which was accompanied by increased CTLA-4 expression in tumor-infiltrating CD4 + T cells. In vitro co-culture experiments also showed that tumor cell CEBPB overexpression increased CTLA4 in T cells.

Conclusions

Tumor cell CEBPB expression, up-regulated by TP53 mutation, can increase CTLA4 expression in T cells and negatively affect patient outcomes. These findings suggested a central role of tumor cell CEBPB in shaping an immunosuppressive TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCCAAT-Enhancer-Binding Protein-betaCTLA-4 AntigenTumor EscapeT-LymphocytesAnimalsHumansMiceTumor MicroenvironmentTumor Suppressor Protein p53Cell Line, TumorGene Expression Regulation, NeoplasticUp-RegulationFemaleMaleLymphocytes, Tumor-InfiltratingImmunoediting, Cancer

Substanzen

CCAAT-Enhancer-Binding Protein-betaCTLA-4 AntigenTumor Suppressor Protein p53CTLA4 protein, humanCEBPB protein, humanCebpb protein, mouseCtla4 protein, mouse

Autor:innen und Institutionen

  • Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Bioinformatics, Soongsil University, Seoul, Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Lunit Inc., Seoul, Korea.

ORCID-Profile: Junil Kim, Sae-Won Han

Förderung

  • Ministry of Science and ICT, South Korea
  • Seoul National University Hospital

Zitieren

APA

Yun, H. J., Park, C. H., Yun, D., Shin, H. R., Lee, J. D., Park, C., Kim, K., Shim, H., Sim, H., Kim, S. M., Kim, M. J., Park, J. W., Ryoo, S. B., Lim, Y., Jeong, S. Y., Park, K. J., Kim, T. Y., Kim, J., Won, J. K., & Han, S. W. (2026). CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0013

Vancouver

Yun HJ, Park CH, Yun D, Shin HR, Lee JD, Park C, et al. CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells. Cancer Communications. 2026;46. doi:10.34133/cancomm.0013

BibTeX
@article{Yun2026,
  author = {Yun, Hye Jeong and Park, Chan Ho and Yun, Dahye and Shin, Hye-Ri and Lee, Jeong Dong and Park, Changhee and Kim, Kiyeon and Shim, Heejun and Sim, Hyejin and Kim, Se Min and Kim, Min Jung and Park, Ji Won and Ryoo, Seung-Bum and Lim, Yoojoo and Jeong, Seung-Yong and Park, Kyu Joo and Kim, Tae-You and Kim, Junil and Won, Jae-Kyung and Han, Sae-Won},
  title = {CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0013}
}
Kostenlos starten →